NCT06914804

Brief Summary

People living with an ileostomy may often experience leaks from their stoma pouches. Leakages are a highly stressful experience, so it is no surprise that worry about leaks is very common among ileostomates and this can contribute to increased anxiety and impact negatively on quality of life. Ileostomates will make changes to their lifestyle to minimise the occurrence of leaks; they may avoid travelling long distances, steer clear of busy social events and often restrict certain food(s) and / or drink(s). The latter stands in the way of achieving a healthy balanced diet and can put ileostomates at risk of developing nutritional deficiencies. Researchers at ulster university have developed a leak sensor device which can be worn unobtrusively alongside any stoma pouch. The device can detect the early stages of a leak from the stoma bag and alerts the user, meaning they are able to change their pouch before it's too late. Participants will be asked to trial 2 versions of the device, each over a 2-week period. At the beginning and end of each period participants will complete a series of questionnaires to allow the research team to determine device efficacy and impact on quality of life. Food diaries will also be completed by participants to give an indication of how dietary intake can impact the incidence of pouch leakage.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 26, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 6, 2025

Completed
8 days until next milestone

Study Start

First participant enrolled

April 14, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2026

Completed
Last Updated

April 6, 2025

Status Verified

March 1, 2025

Enrollment Period

10 months

First QC Date

March 26, 2025

Last Update Submit

April 2, 2025

Conditions

Keywords

IleostomyStoma-pouch leakageperistomal skindietary intakequality of life

Outcome Measures

Primary Outcomes (7)

  • Psychiatric morbidity

    Psychiatric morbidity will be assessed at the beginning and end of each test period using the General Health Questionnaire (GHQ-12).

    Comparison between treatments over a 2-week period.

  • Psychological well-being

    Psychological well-being will be assessed at the beginning and end of each test period using the Warwick-Edinburgh Mental Well-being Scale (WEMWBS)

    Comparison between treatments over a 2-week period.

  • General quality of life

    General quality of life will be assessed at the beginning and end of each test period using the European Organization for Research and Treatment of Cancer (EORTC) QoL questionnaire for colorectal cancer (EORTCQLQ-CR38).

    Comparison between treatments over a 2-week period.

  • General quality of life

    General quality of life will be assessed at the beginning and end of each test period using the The World Health Organization Quality of Life - BREF (WHOQOL-BREF).

    Comparison between treatments over a 2-week period.

  • Stress and coping

    Stress and coping will be assessed at the beginning and end of each test period using the Perceived Stress Scale (PSS), which is a global measure of stress

    Change over 2 weeks comparison between treatments

  • Resillience

    Resillience will be assessed at the beginning and end of each test period using the Connor-Davidson Resilience Scale (CD-RISC)

    Change over 2 weeks comparison between treatments

  • Stoma related quality of life

    Stoma related quality of life will be assessed at the beginning and end of each test period using the Stoma QoL: A Quality-of-Life Questionnaire for People with an Ostomy

    Comparison between treatments over a 2-week period.

Secondary Outcomes (4)

  • Device accuracy

    Measured over 2 weeks comparison between treatments

  • Device usability

    Measured at 2 weeks comparison between treatments

  • Dietary intake

    Measured over 2 weeks comparison between treatments

  • Peristomal skin condition

    Comparison between treatments over a 2-week period.

Study Arms (2)

Leak detection device (microbutton probes)

EXPERIMENTAL

Leakage events will be detected by microbutton probes, which are attached to the sensing device

Device: Stomasense

Leak detection device (microwire probes)

EXPERIMENTAL

Leakage events will be detected by microwire probes, which are attached to the sensing device

Device: Stomasense

Interventions

A smart device worn alongside stoma pouch systems which detects onset of a leak.

Leak detection device (microbutton probes)Leak detection device (microwire probes)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Living with an ileostomy
  • ≥1.5-years post-operative
  • Aged 18+ years
  • Experiencing frequent leaks (i.e., more than once per week)
  • Males and females (not currently pregnant/lactating)
  • Self-manging their own stoma
  • Access to computer / mobile device for survey completion
  • No learning or other disabilities
  • Have never used / trialled other leak detection systems

You may not qualify if:

  • Never had an ileostomy,
  • Individuals with previous ileostomy or ostomy (colostomy or urostomy)
  • \<1.5-year post-operative
  • \<18 years
  • Do not experience frequent leaks (i.e., less than once per week)
  • Adults with learning or other disabilities
  • Have previously used other leak detection systems
  • Pregnant/lactating female

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ulster University, Human Intervention Studies Unit

Coleraine, Co. Derry, BT521SA, United Kingdom

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 26, 2025

First Posted

April 6, 2025

Study Start

April 14, 2025

Primary Completion

January 31, 2026

Study Completion

January 31, 2026

Last Updated

April 6, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations